Literature DB >> 14695721

High incidence of myocardial ischemia during postpartum hemorrhage.

Peter C J Karpati1, Mathias Rossignol, Marcus Pirot, Bernard Cholley, Eric Vicaut, Patrick Henry, Jean-Philippe Kévorkian, Patrick Schurando, Jacqueline Peynet, Denis Jacob, Didier Payen, Alexandre Mebazaa.   

Abstract

BACKGROUND: Postpartum hemorrhage remains a major cause of global maternal morbidity and mortality, even in developed countries, despite the use of intensive care units. This study sought to (1) assess whether myocardial ischemia could be associated with and even aggravate hemorrhagic shock in young parturients admitted for postpartum hemorrhage, and (2) identify the independent risk factors for myocardial ischemia.
METHODS: On their referral to the intensive care unit, a multidisciplinary team managed parturients with severe postpartum hemorrhage. Ventilation, transfusion, catecholamines, surgery, or angiography with uterine embolization were provided as clinically indicated. Plasma cardiac troponin I levels were used as a surrogate marker of acute myocardial injury and electrocardiograms of myocardial ischemia.
RESULTS: A total of 55 parturients were referred with severe postpartum hemorrhage, all in hemorrhagic shock. Twenty-eight parturients (51%) had elevated serum levels of cardiac troponin I (9.4 microg/l [3.7-26.6 microg/l]), which were associated with electrocardiographic signs of ischemia and deteriorated myocardial contractility and correlated with the severity of hemorrhagic shock. Indeed, multivariate analysis identified low systolic and diastolic arterial blood pressure (< 88 and < 50 mmHg, respectively) and increased heart rate (> 115 beats/min) as independent predictors of myocardial injury. In addition, all patients who were given catecholamines also had elevated cardiac troponin I levels.
CONCLUSIONS: These results suggest that treatment of postpartum hemorrhage-induced hemorrhagic shock should be coupled with concomitant prevention of myocardial ischemia, even in young parturients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14695721     DOI: 10.1097/00000542-200401000-00009

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  12 in total

1.  Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study.

Authors:  Etienne Gayat; Matthieu Resche-Rigon; Olivier Morel; Matthias Rossignol; Jean Mantz; Armelle Nicolas-Robin; Nathalie Nathan-Denizot; Jean-Yves Lefrant; Frédéric J Mercier; Emmanuel Samain; Yann Fargeaudou; Emmanuel Barranger; Marie-Josèphe Laisné; Pierre-Henri Bréchat; Dominique Luton; Ingrid Ouanounou; Patricia Appa Plaza; Claire Broche; Didier Payen; Alexandre Mebazaa
Journal:  Intensive Care Med       Date:  2011-07-30       Impact factor: 17.440

2.  Methylergonovine maleate and the risk of myocardial ischemia and infarction.

Authors:  Brian T Bateman; Krista F Huybrechts; Sonia Hernandez-Diaz; Jun Liu; Jeffrey L Ecker; Jerry Avorn
Journal:  Am J Obstet Gynecol       Date:  2013-07-11       Impact factor: 8.661

3.  Cardiovascular disease and cancer in women with accreta and retained placenta: a longitudinal cohort study.

Authors:  Nathalie Auger; Sophie Marcoux; Gilles Paradis; Jessica Healy-Profitós; Shu Qin Wei; Brian J Potter
Journal:  Arch Gynecol Obstet       Date:  2021-04-04       Impact factor: 2.344

4.  Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement.

Authors:  Manuel Muñoz; Jakob Stensballe; Anne-Sophie Ducloy-Bouthors; Marie-Pierre Bonnet; Edoardo De Robertis; Ino Fornet; François Goffinet; Stefan Hofer; Wolfgang Holzgreve; Susana Manrique; Jacky Nizard; François Christory; Charles-Marc Samama; Jean-François Hardy
Journal:  Blood Transfus       Date:  2019-02-06       Impact factor: 3.443

5.  Independent early predictors of mortality in polytrauma patients: a prospective, observational, longitudinal study.

Authors:  Luiz Guilherme V da Costa; Maria José C Carmona; Luiz M Malbouisson; Sandro Rizoli; Joel Avancini Rocha-Filho; Ricardo Galesso Cardoso; José Otávio C Auler-Junior
Journal:  Clinics (Sao Paulo)       Date:  2017-08       Impact factor: 2.365

6.  Anesthetic review of emergency peripartum hysterectomy following vaginal and cesarean delivery: a retrospective study.

Authors:  In Ho Lee; Ju Hyung Son; Young Chul Shin; Jae Hoon Byun; Hea Jo Yoon; Young Seok Jee
Journal:  Korean J Anesthesiol       Date:  2012-07-24

7.  Peripartum Haemorrhage, Diagnosis and Therapy. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/063, March 2016).

Authors:  Dietmar Schlembach; Hanns Helmer; Wolfgang Henrich; Christian von Heymann; Franz Kainer; Wolfgang Korte; Maritta Kühnert; Heiko Lier; Holger Maul; Werner Rath; Susanne Steppat; Daniel Surbek; Jürgen Wacker
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-04-26       Impact factor: 2.915

8.  Restrictive Versus Massive Fluid Resuscitation Strategy (REFILL study), influence on blood loss and hemostatic parameters in obstetric hemorrhage: study protocol for a randomized controlled trial.

Authors:  Natascha de Lange; Pim Schol; Marcus Lancé; Mallory Woiski; Josje Langenveld; Robbert Rijnders; Luc Smits; Martine Wassen; Yvonne Henskens; Hubertina Scheepers
Journal:  Trials       Date:  2018-03-06       Impact factor: 2.279

9.  Cardiac troponin and skeletal muscle oxygenation in severe post-partum haemorrhage.

Authors:  Laurent Heyer; Alexandre Mebazaa; Etienne Gayat; Matthieu Resche-Rigon; Christophe Rabuel; Eva Rezlan; Anne-Claire Lukascewicz; Catharina Madadaki; Romain Pirracchio; Patrick Schurando; Olivier Morel; Yann Fargeaudou; Didier Payen
Journal:  Crit Care       Date:  2009-11-30       Impact factor: 9.097

10.  Prinzmetal's Angina in a Pregnant Woman: a Case Report.

Authors:  Fariba Almassinokiani; Mahmood Reza Alebouyeh; Farshad Entesari; Seyed Hashem Sezavar Seyedi; Alireza Almasi; Hossein Akbari; Hossein Saidi; Homa Homam
Journal:  J Tehran Heart Cent       Date:  2012-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.